Table 1 The dysregulated SFs in HCC tumor tissues compared with adjacent normal tissues.

MBNL2

2.80E−10

3.61E−09

SRSF8

1.79E−15

1.38E−13

SRSF5

1.39E−16

2.68E−14

DDX19B

1.62E−13

6.97E−12

C9orf78

1.55E−14

9.96E−13

QKI

1.56E−15

1.38E−13

MBNL3

0.001953

0.0044613

DDX3X

9.73E−14

4.69E−12

RBMXL1

3.56E−10

4.16E−09

RBMS1

3.42E−06

1.43E−05

ZC3H13

3.06E−08

2.19E−07

INTS6

1.72E−09

1.66E−08

RBM7

2.88E−17

1.11E−14

CLK1

3.85E−08

2.44E−07

CELF2

0.000323

0.0008978

SRSF6

1.24E−12

4.07E−11

PPIL4

3.64E−12

8.26E−11

RBM47

6.02E−06

2.40E−05

PRPF3

9.93E−10

1.01E−08

DDX41

1.79E−09

1.69E−08

PUF60

9.71E−09

7.65E−08

THOC5

1.37E−12

4.07E−11

RBM3

2.32E−07

1.22E−06

PRCC

1.37E−11

2.79E−10

SNRPB

4.35E−10

4.94E−09

LSM4

7.08E−08

3.90E−07

MSI1

0.000145

0.00044808

ILF2

1.37E−12

4.07E−11

RNF213

6.10E−07

2.94E−06

SNRPE

7.28E−11

1.17E−09

DHX34

8.30E−16

1.07E−13

SF3B4

4.35E−13

1.68E−11

FAM50A

5.15E−09

4.23E−08

PCBP4

6.57E−10

7.24E−09

IGF2BP3

2.29E−07

1.22E−06

NELFE

1.52E−12

4.20E−11

DDX39A

6.63E−14

3.66E−12

HSPB1

3.45E−08

2.36E−07

DNAJC6

1.39E−10

1.98E−09

CDC40

7.86E−10

8.43E−09